Tainet Communication System (4905) reported revenue of NT$87.8 million for Oct 2026, +21.0% year on year and +16.5% from the previous month. Revenue for Jan–Oct 2026 was NT$805 million (+35.6% year on year).
Year-on-year revenue growth: 5 months in a row. →
In Oct 2026, it ranked No. 81 by revenue among 160 Biotech & Medical companies.
Monthly revenue chart
Hover over (or tap) a bar to see that month’s revenue.
Monthly revenue history
| Month | Revenue | YoY | MoM |
|---|---|---|---|
| Oct 2026 | NT$87.8 million | +21.0% | +16.5% |
| Sep 2026 | NT$75.3 million | +36.7% | -18.0% |
| Aug 2026 | NT$91.8 million | +68.2% | -11.8% |
| Jul 2026 | NT$104.2 million | +35.4% | +32.8% |
| Jun 2026 | NT$78.4 million | +75.3% | +4.9% |
| May 2026 | NT$74.7 million | -0.5% | -11.1% |
| Apr 2026 | NT$84.1 million | +31.6% | +23.2% |
| Mar 2026 | NT$68.2 million | +56.9% | +16.3% |
| Feb 2026 | NT$58.7 million | +21.7% | -28.2% |
| Jan 2026 | NT$81.7 million | +38.1% | +14.8% |
| Dec 2025 | NT$71.2 million | +9.4% | +14.6% |
| Nov 2025 | NT$62.1 million | +47.2% | -14.4% |
| Oct 2025 | NT$72.5 million | +12.3% | +31.6% |
| Sep 2025 | NT$55.1 million | +31.3% | +0.9% |
| Aug 2025 | NT$54.6 million | -1.8% | -29.0% |
| Jul 2025 | NT$76.9 million | +30.6% | +72.0% |
| Jun 2025 | NT$44.7 million | +11.8% | -40.5% |
| May 2025 | NT$75.1 million | +38.4% | +17.6% |
| Apr 2025 | NT$63.9 million | +32.8% | +46.9% |
| Mar 2025 | NT$43.5 million | -16.7% | -9.8% |
| Feb 2025 | NT$48.2 million | +32.7% | -18.5% |
| Jan 2025 | NT$59.2 million | +72.8% | -9.0% |
| Dec 2024 | NT$65.1 million | +587.7% | +54.3% |
| Nov 2024 | NT$42.2 million | +382.1% | -34.7% |
| Oct 2024 | NT$64.6 million | +525.1% | +53.9% |
Jan–Oct 2026 cumulative: NT$805 million (+35.6% YoY)
Other Biotech & Medical companies
Compare with peers: Tainet Communication System vs PEC / Tainet Communication System vs Lotus Pharm / Tainet Communication System vs Bora
| Company | Revenue | YoY |
|---|---|---|
| PEC | NT$2.84 billion | +102.0% |
| Lotus Pharm | NT$2.13 billion | -22.5% |
| Bora | NT$1.99 billion | +15.9% |
| Great Tree Pharmacy | NT$1.67 billion | +1.5% |
| EXCELSIOR | NT$1.02 billion | +38.6% |
| PEGAVISION | NT$793 million | +13.0% |
| Synmosa Biopharma | NT$766.6 million | +41.2% |
| Y.S.H. | NT$749.4 million | +4.4% |
See also
← All Taiwan listed & OTC companies
Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16